Evidence map›Paper›PMID 29887891›Full record

ReviewObstetrics and gynecology international2018

Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.

Yeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, Tanya Chawla, Eran Shlomovitz, Sarah Buchanan, Jenny Lau, Jennifer Croke, Johane P Allard, Preeti Dhar and 10 more

Open access · goldAbstract readReview
In one paragraph

Review in Obstetrics and gynecology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. What is the evidence for dietary modification in the management and prevention of malignant bowel obstruction? A scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  10. Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Ultrasound-guided percutaneous venting duodenostomy: New technique.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 1 country.

Yeh Chen LeeDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Nazlin JivrajPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Catherine O'BrienDivision of General Surgery, University Health Network, Toronto, ON, Canada.
Tanya ChawlaJoint Department of Medical Imaging, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Eran ShlomovitzDivision of General Surgery, University Health Network, Toronto, ON, Canada.
Sarah BuchananPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Jenny LauDivision of Supportive Care, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Jennifer CrokeRadiation Medicine Program, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Johane P AllardDivision of Gastroenterology, University Health Network, University of Toronto, Toronto, ON, Canada.
Preeti DharDivision of General Surgery, University Health Network, Toronto, ON, Canada.
Stephane LaframboiseDivision of Gynecologic Oncology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Sarah E FergusonDivision of Gynecologic Oncology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Neesha DhaniDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Marcus ButlerDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Pamela NgPrincess Margaret Cancer Centre, Toronto, ON, Canada.
Terri Stuart-McEwanSolid Tumour Oncology and Gattuso Rapid Diagnostic Centre, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Pamela SavagePrincess Margaret Cancer Centre, Toronto, ON, Canada.
Lisa TinkerAmbulatory Care-Solid Tumour Oncology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Amit M OzaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.
Stephanie LheureuxDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada.ORCID 0000-0003-4405-5890
University Health Network · CAPrincess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant bowel obstruction (MBO) is a major complication in women with advanced gynecologic cancers which imposes a significant burden on patients, caregivers, and healthcare systems. Symptoms of MBO are challenging to palliate and result in progressive decompensation of already vulnerable patients with limited therapeutic options and a short prognosis. However, there is a paucity of guidelines or innovative approaches to improve the care of women who develop MBO. MBO is a complex clinical situation that requires a multidisciplinary approach to ensure the appropriate treatment modality and interprofessional care to optimally manage these patients. This review summarizes the current literature on the different approaches targeting MBO management including surgical intervention, chemotherapy, total parenteral nutrition, and pharmacological treatment. In addition, the impact of MBO management on patients' quality of life (QOL) is examined. This article focuses on the challenges in developing evidence-based treatment guidelines for MBO and barriers in clinical trial design for MBO and proposes strategies to advance the MBO management. Collaboration is essential to design studies that may improve the overall care and quality of life for these patients. Prospective data are needed to inform clinical practice, establish a new benchmark for evidence-based MBO management, and better understand the biology of MBO.

Identifiers

PMID29887891
PMCPMC5985138
OpenAlexW2803466357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.